(UZU) Uzin Utz - Ratings and Ratios
Flooring Systems, Adhesives, Machines, Cleaning Products, Flooring Services
Description: UZU Uzin Utz
Uzin Utz SE is a leading manufacturer of construction chemical system products, operating globally with a presence in Germany, the United States, Netherlands, and other countries. The company offers a diverse range of products, including laying systems for floors, parquet, tiles, and natural stone, as well as synthetic resin flooring products and surface finishing solutions.
With a strong brand portfolio, including UZIN, WOLFF, PALLMANN, Arturo, codex, and Pajarito, Uzin Utz SE has established itself as a reputable player in the specialty chemicals industry. The companys product systems cater to various aspects of floor installation and maintenance, including high-performance dry adhesives, cleaning and maintenance products, and floor-related services.
From a financial perspective, Uzin Utz SE has demonstrated a robust performance, with a Return on Equity (RoE) of 19.98%, indicating a strong ability to generate profits from shareholder equity. The companys Market Capitalization stands at 305.18M EUR, with a Price-to-Earnings (P/E) ratio of 10.36, suggesting a relatively attractive valuation. Additionally, key performance indicators such as Revenue Growth, EBITDA Margin, and Debt-to-Equity ratio would provide further insights into the companys financial health and operational efficiency.
To further evaluate Uzin Utz SEs investment potential, it would be essential to analyze its revenue diversification across different regions and product segments, as well as its ability to maintain a competitive edge in the market. Other relevant KPIs, such as Gross Margin, Operating Cash Flow, and Capital Expenditure, would also provide valuable insights into the companys financial performance and growth prospects.
UZU Stock Overview
| Market Cap in USD | 449m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
UZU Stock Ratings
| Growth Rating | 46.5% |
| Fundamental | 80.5% |
| Dividend Rating | 54.3% |
| Return 12m vs S&P 500 | 32.3% |
| Analyst Rating | - |
UZU Dividends
| Dividend Yield 12m | 2.96% |
| Yield on Cost 5y | 4.12% |
| Annual Growth 5y | 4.24% |
| Payout Consistency | 93.2% |
| Payout Ratio | 40.1% |
UZU Growth Ratios
| Growth Correlation 3m | 84.1% |
| Growth Correlation 12m | 93.1% |
| Growth Correlation 5y | -24.7% |
| CAGR 5y | 10.36% |
| CAGR/Max DD 5y | 0.19 |
| Sharpe Ratio 12m | -0.12 |
| Alpha | 46.40 |
| Beta | 0.585 |
| Volatility | 39.43% |
| Current Volume | 0.1k |
| Average Volume 20d | 1k |
| Stop Loss | 69.8 (-3.1%) |
| Signal | 2.54 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (52.0m TTM) > 0 and > 6% of Revenue (6% = 57.3m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 8.77pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.17% (prev 8.49%; Δ -1.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.24 (>3.0%) and CFO 101.8m > Net Income 52.0m (YES >=105%, WARN >=100%) |
| Net Debt (36.9m) to EBITDA (161.3m) ratio: 0.23 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (5.04m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 41.54% (prev 29.52%; Δ 12.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 224.5% (prev 144.7%; Δ 79.84pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.97 (EBITDA TTM 161.3m / Interest Expense TTM 7.15m) >= 6 (WARN >= 3) |
Altman Z'' 6.31
| (A) 0.16 = (Total Current Assets 161.6m - Total Current Liabilities 93.0m) / Total Assets 431.0m |
| (B) 0.52 = Retained Earnings (Balance) 223.5m / Total Assets 431.0m |
| (C) 0.29 = EBIT TTM 121.3m / Avg Total Assets 425.5m |
| (D) 1.58 = Book Value of Equity 238.7m / Total Liabilities 150.7m |
| Total Rating: 6.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.46
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 16.14% = 5.0 |
| 3. FCF Margin 7.02% = 1.75 |
| 4. Debt/Equity 0.26 = 2.47 |
| 5. Debt/Ebitda 0.46 = 2.34 |
| 6. ROIC - WACC 23.07% = 12.50 |
| 7. RoE 19.98% = 1.67 |
| 8. Rev. Trend 33.34% = 1.67 |
| 9. Rev. CAGR 1.95% = 0.24 |
| 10. EPS Trend -24.69% = -0.62 |
| 11. EPS CAGR 4.37% = 0.44 |
What is the price of UZU shares?
Over the past week, the price has changed by -2.70%, over one month by +11.63%, over three months by +22.03% and over the past year by +54.78%.
Is Uzin Utz a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UZU is around 80.08 EUR . This means that UZU is currently undervalued and has a potential upside of +11.22% (Margin of Safety).
Is UZU a buy, sell or hold?
What are the forecasts/targets for the UZU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 78.5 | 9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 88.1 | 22.3% |
UZU Fundamental Data Overview
Market Cap EUR = 385.9m (385.9m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 44.4m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 13.0993
P/S = 0.7934
P/B = 1.3868
Beta = 0.901
Revenue TTM = 955.4m EUR
EBIT TTM = 121.3m EUR
EBITDA TTM = 161.3m EUR
Long Term Debt = 30.9m EUR (from longTermDebt, last quarter)
Short Term Debt = 43.1m EUR (from shortTermDebt, last quarter)
Debt = 74.0m EUR (Calculated: Short Term 43.1m + Long Term 30.9m)
Net Debt = 36.9m EUR (from netDebt column, last quarter)
Enterprise Value = 415.5m EUR (385.9m + Debt 74.0m - CCE 44.4m)
Interest Coverage Ratio = 16.97 (Ebit TTM 121.3m / Interest Expense TTM 7.15m)
FCF Yield = 16.14% (FCF TTM 67.1m / Enterprise Value 415.5m)
FCF Margin = 7.02% (FCF TTM 67.1m / Revenue TTM 955.4m)
Net Margin = 5.45% (Net Income TTM 52.0m / Revenue TTM 955.4m)
Gross Margin = 41.54% ((Revenue TTM 955.4m - Cost of Revenue TTM 558.5m) / Revenue TTM)
Tobins Q-Ratio = 1.74 (Enterprise Value 415.5m / Book Value Of Equity 238.7m)
Interest Expense / Debt = 1.31% (Interest Expense 972.0k / Debt 74.0m)
Taxrate = 25.85% (from yearly Income Tax Expense: 10.3m / 39.8m)
NOPAT = 90.0m (EBIT 121.3m * (1 - 25.85%))
Current Ratio = 1.74 (Total Current Assets 161.6m / Total Current Liabilities 93.0m)
Debt / Equity = 0.26 (Debt 74.0m / last Quarter total Stockholder Equity 280.1m)
Debt / EBITDA = 0.46 (Net Debt 36.9m / EBITDA 161.3m)
Debt / FCF = 1.10 (Debt 74.0m / FCF TTM 67.1m)
Total Stockholder Equity = 260.4m (last 4 quarters mean)
RoA = 12.07% (Net Income 52.0m, Total Assets 431.0m )
RoE = 19.98% (Net Income TTM 52.0m / Total Stockholder Equity 260.4m)
RoCE = 41.65% (Ebit 121.3m / (Equity 260.4m + L.T.Debt 30.9m))
RoIC = 30.08% (NOPAT 90.0m / Invested Capital 299.1m)
WACC = 7.01% (E(385.9m)/V(459.9m) * Re(8.17%)) + (D(74.0m)/V(459.9m) * Rd(1.31%) * (1-Tc(0.26)))
Shares Correlation 5-Years: 35.40 | Cagr: 0.0%
Discount Rate = 8.17% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 69.91% ; FCFE base≈51.6m ; Y1≈33.9m ; Y5≈15.5m
Fair Price DCF = 59.16 (DCF Value 298.4m / Shares Outstanding 5.04m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 33.34 | Revenue CAGR: 1.95%
Rev Growth-of-Growth: 13.88
EPS Correlation: -24.69 | EPS CAGR: 4.37%
EPS Growth-of-Growth: 119.3